Updated Guidelines for the Treatment of Acquired Aplastic Anemia in Children
- 30 June 2018
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Oncology Reports
- Vol. 20 (9), 67
- https://doi.org/10.1007/s11912-018-0716-8
Abstract
This review aimed to provide updated guidelines for the management of children with acquired aplastic anemia (AA), particularly focusing on hematopoietic stem cell transplantation (HSCT).Keywords
This publication has 79 references indexed in Scilit:
- How I manage aplastic anaemia in childrenBritish Journal of Haematology, 2012
- Predicting response to immunosuppressive therapy in childhood aplastic anemiaHaematologica, 2011
- Influence of Nucleated Cell Dose on Overall Survival of Unrelated Cord Blood Transplantation for Patients with Severe Acquired Aplastic Anemia: A Study by Eurocord and the Aplastic Anemia Working Party of the European Group for Blood and Marrow TransplantationTransplantation and Cellular Therapy, 2010
- Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working partyPublished by Ferrata Storti Foundation (Haematologica) ,2010
- Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemiaBone Marrow Transplantation, 2010
- Long-Term Outcome of Pediatric Patients with Severe Aplastic Anemia Treated with Antithymocyte Globulin and CyclosporineThe Journal of Pediatrics, 2008
- Clinical and Genetic Analysis of Unclassifiable Inherited Bone Marrow Failure SyndromesPublished by American Academy of Pediatrics (AAP) ,2008
- Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimensBlood, 2007
- Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failureBlood Cells, Molecules, and Diseases, 2005
- Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNAThe Lancet, 2003